Clinical Trial Update: An Observational Study to Assess Change in Disease Activity and Adverse Events of Rinvoq in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Japan

View source ↗

Summary

This report covers the completion of an observational study in Japan evaluating changes in Ulcerative Colitis disease activity and adverse events in adults trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• RINVOQ (Upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Ulcerative Colitis | Status: COMPLETED